A generic alternative indicated for oncology support. This treatment disrupts active cellular growth cycles to manage the progression of specific malignant conditions.
This chemotherapy agent is indicated to manage multiple myeloma and ovarian cancer to alleviate tumor progression and support patient survival.
Mechanism of Action
It works by attaching an alkyl group to DNA, which causes cross-linking and breaks in the DNA strands. This prevents cancer cells from dividing and replicating.
Route of Administration
Oral
Onset Time
Variable
Duration
Variable
Contraindications
Pregnancy, Severe bone marrow suppression, Previous resistance to melphalan, Allergy to melphalan
Severe Adverse Events
Severe bone marrow suppression, Life-threatening infections, Pulmonary fibrosis, Secondary leukemia
Common Side Effects
Nausea, Vomiting, Diarrhea, Loss of appetite
Uncommon Side Effects
Mouth sores, Hair thinning, Skin rash, Fatigue
Drug Interactions
Cyclosporine, Live vaccines, Cimetidine, Carmustine
Pregnancy Safety Warnings
Contraindicated; can cause severe fetal harm and infertility.
Age Restrictions
As prescribed by an oncologist.
Storage Guidelines
Store in refrigerator (2°C to 8°C). Protect from light.
Information for Alkacel is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
